chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash; dry, itchy scalp and hair loss; dry, itchy scalp and hair loss; dry, itchy scalp and hair loss; tired; shingles; This is a spontaneous report from a contactable consumer or other non hcp.   A 64-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, Batch/Lot Number: EW0185), via an unspecified route of administration on 21May2021 (64-year-old at the time of vaccination) as a 2nd dose, single dose for COVID-19 immunization. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, solution for injection, Batch/Lot Number: EW0158), via an unspecified route of administration on 20Apr2021, as a 1st dose, single dose for COVID-19 immunization. The patient's medical history included take blood pressure medicine for high blood pressure daily and also takes vitamins, but other than that she wasn't sick and she wasn't taking anything else. She was allergic to shellfish. On 08Jun2021, the patient experienced shingles, she says that the shingles happened yesterday and she thought that it was just a rash and then she decided to call the dermatologist. It got worse today and it was also painful. That's how she figured it out that it was shingles, on an unspecified date, rash, dry, itchy scalp and hair loss then she started seeing hair loss and she was also a little itchy but now it was worse than it has ever been. She has put on coconut oil to soothe it but it has been going on for about the last week or week and a half, and tired. The dermatologist told her it was due to the Pfizer vaccine and told to take Valtrex and use a Silvadene cream topical and other stuff for her head. Her main concern was that her doctor told her that this was a side effect and she was just going by what the doctor had said. She was not under stress, she has been tired for a long time and she lives a good life. She was lucky but it just popped up and she knows that shingles was related to stress and other issues but the doctor said that the COVID vaccine does bring it out. The outcome of the event tired was unknown and all the other events were not recovered.  No follow-up attempts possible. No further information expected.
Large 5cm X 6cm raised rash treated with hydrocortisone. Symptoms appeared the night of initial injection.
VASOVAGAL, MEMBER FELT LIGHTHEADED AND DIZZY.  NO LOSS OF CONSCIOUSNESS, MEMBER LAID DOWN IN A PATIENT BED AND VITAL SIGNS WERE TAKEN.  NO MEDICATION WAS ADMINISTERED.  WERE WAS SUPERVISED FOR AROUND 30 MINS TO MAKE SURE HE DIDN'T GET WORSE.
On monday morning may 10, we went to emergency at 1am in the morning.  My wife started to get red spots on her front chest, lower abdomen, and back on may 8.  Over a couple days it got more red and more dots.  The morning of may 10 it got ichy so she couldn't sleep and found there were more red dots so we went to emergency.  Doctor checked on it and said her experience is it will go away after a week.  It has been a few days and there are less dots and they are slightly less red.  Hopefully it will completely go away.  At the hospital she was given one pill of benadryl and a liquid steroid.  she was prescribed benadryl but she didn't want to take it.
SORENESS; CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a parent concerned a 31 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included: autistic. He experienced allergy to amoxicillin when treated with Amoxicillin. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration was not reported, batch number: 1805022 and expiry: unknown) dose was not reported, 1 total administered on left arm on 13-MAR-2021 for prophylactic vaccination. Concomitant medications included Abilify (aripiprazole) used for unknown indication which caused him to have high triglycerides but he did not take anything for the high triglycerides. On an unspecified date, the patient experienced some soreness after getting the Janssen COVID-19 vaccine. He experienced nausea, diarrhea, fever, headaches, sinus congestion, and loss of smell. On 18-AUG-2021, COVID-19 virus test result was positive which confirmed covid-19 infection. On the same date, he reported confirmed clinical vaccination failure.   The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from confirmed covid-19 infection, and soreness, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211043553 and 20211043945. This report was associated with product quality complaint number: 90000198697.; Sender's Comments: V0 20211043252-COVID-19 VACCINE AD26.COV2.S-confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS.
Not feeling too good; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling too good) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling too good). At the time of the report, MALAISE (Not feeling too good) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Vaccination was placed into the nerve of the left arm. I reported to my doctor, because the pain was very intense, and she told me that it may take a tear to go away. My doctor prescribed Gabapentin 300 mg capsules for the pain. however, it hasn't solved or helped the pain. I still have a great deal of constant pain keeps me from working long periods of 30 minutes or longer. It hurts when I'm just sitting still watching television and any other (Adl's activities of Daily Living). I am reporting the issue now because I first took mt doctors advise and hoped it would stop in a year as she stated. But it has not stopped the pain continues to persist everyday.
have a positive reaction to the vaccine so beneficial/Within hours of receiving the vaccine that began to go away; More a soreness from a shot in the muscle; My arm at the site was sore; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "I had a ongoing weakness, pain in my legs" (unspecified if ongoing), notes: I had a ongoing weakness, pain in my legs.; "I had a ongoing weakness, pain in my legs" (unspecified if ongoing), notes: I had a ongoing weakness, pain in my legs. The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "have a positive reaction to the vaccine so beneficial/Within hours of receiving the vaccine that began to go away"; MYALGIA (non-serious), outcome "unknown", described as "More a soreness from a shot in the muscle"; VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "My arm at the site was sore".  Additional information: The patent state that she didn't know how/who to contact but she did not have any adverse side effects to the vaccine. Her arm at the site was sore you could tell she had gotten a shot, more a soreness from a shot in the muscle. She did feel something in her arm. It wasn't anything bad, no worse than any other shot in the arm. She did have a positive reaction to the vaccine so beneficial to her (don't know what was in it that was so beneficial to her). She had an ongoing weakness, pain in her legs. It was there for several years. Within hours of receiving the vaccine that began to go away, the pain and the weakness (in her legs). She would like to know what was in the vaccine that was so beneficial to her? It had done things for her that can benefit so many other people that had dealt with weakness and pain in their legs. That was why she wanted to tell Pfizer. The patient declined to have the ingredient list sent to her she stated, "Her doctor has that. She had not been to the doctor, but she was sure my doctor has that. She intends to let her doctor. In the past many drugs were developed to treat one thing but was also good treatment for a totally different thing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
TENIVAC and FLUZONE QUADRIVALENT exceeded the stability data and were administered to patients with no reported AE; poor quality dose administered with no adverse event; Initial information received on 12-Oct-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 48 years old (unknown gender) patient who reported tenivac and fluzone quadrivalent exceeded the stability data and were administered to patients with no reported adverse event and poor quality dose administered with no adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] and DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] .  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 23-Sep-2022, the patient received a  dose of suspect  INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED  (lot UJ899AA; 30-Jun-2023) via unknown route in unknown administration site and DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (strength, dose, formulation, route: unknown) both for Immunization.  On 23-SEP-2022 the patient developed a non-serious event tenivac and fluzone quadrivalent exceeded the stability data and were administered to patients with no reported adverse event (product storage error) and poor quality dose administered (poor quality product administered)  with no adverse event following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED and DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the events.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01318334: 01318560: 01318700: 01318713: 01318730: 01318644: 01318635: 01318655: 01318686: 01318695: 01318744: 01318785: 0131881: 01318811: 01318509: 01318553: 01318603: 01318593: 01318613: 01318624:
Stabbing top back, right side, head pain ( Sat), redness and blisters on right side of face (Wed), right eye pain and blisters (Fri).
Shingles; ongoing joint pain in both feet; ongoing joint pain in both hands; This spontaneous case was reported by a non-health professional and describes the occurrence of ARTHRALGIA (ongoing joint pain in both hands), HERPES ZOSTER (Shingles) and PAIN IN EXTREMITY (ongoing joint pain in both feet) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced ARTHRALGIA (ongoing joint pain in both hands) and PAIN IN EXTREMITY (ongoing joint pain in both feet). On 07-Apr-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, ARTHRALGIA (ongoing joint pain in both hands), HERPES ZOSTER (Shingles) and PAIN IN EXTREMITY (ongoing joint pain in both feet) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: new adverse event reported
I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN- 1/15/2022- PELVIC MASS OF UNSPECIFIED SITE; I82.432 ACUTE DVT OF LEFT POPLITEAL VEIN- 11/29/2021- PELVIC MASS OF UNSPECIFIED SITE; I82.402ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN- 1/15/2022- ANEMIA; I82.432 ACUTE DVT OF LEFT POPLITEAL VEIN - 11/29/2021- ANEMIA; I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN- 1/15/2022- ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN; I82.432 ACUTE DVT OF LEFT POPLITEAL VEIN- 11/29/2021- ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN; I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN- 1/15/2022- SHORTNESS OF BREATH; I82.432  ACUTE DVT OF LEFT POPLITEAL VEIN- 11/29/2021- SHORTNESS OF BREATH.
Acute Vertigo After COVID-19 Vaccination, dizzy, nausea, vomiting
Pt's mom described the rxn as a swollen arm (from elbow to shoulder), stiff neck, an intermittent fever; highest measured temp was 103; swollen arm was treated w/hot compresses & liquid APAP; rxn lasted x 5 days;
Left leg at site of injection red/hot/swollen area 4-5" in diameter, area itches at times.
Nurse calling to report that a vaccine was administered after its expiration date.; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies, or concomitant medications were not reported.   On 11-NOV-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) (rHA) virus vaccine, live (M-M-R II) at a dose of 0.5 milliliters (lot T037028 has been verified to be a valid, expiration date 03-NOV-2022, and upon internal validation established as the same date) for prophylaxis (vaccination scheme, frequency, route of administration, and anatomical site of injection were not reported (expired product administered).
Day #12 s/p smallpox, no prior hx of known allergies nor any h/o suggestive of eczema/ atopic dermatitis; presented with extensive rash. Noticed that it really reupted this am. Does have positive take and last 2 days had erythema/slight swelling around vaccination site-this we have seen a lot of. No systemic symptoms of HA, fever, chills. Feels pretty good other than slight sniffle that he says he picked up from his roommate. Rash clarified in pictures but is extensive macular/papular erythematous distribution including contra-lateral arm/neck/back/chest. Also beginning on chest/legs does appear to be more concentrated on extensor services. Sparing of palms and soles. No appreciated mucosal involvement. Does state a bit itchy-really noticed when taking shower this am. Pt is really not too concerned. To me, right at vaccination site looks a bit like erythema multiforme and distribution would also be consistent with All rxn to one of components of vaccine. Lesions do no t have classic deep red target appearance of EM and looks alot like a drug reaction like after giving ampicillin. No evidence of eczema vaccinatum or generalized vaccinia thank goodness. Pt really no risk factors. Lesions also so extensive that autoimmoculation not really in my differential/ no evidence secondary infection. As just macular-papular though extensive, I have begun symptomatic tx with blocking histamine receptors with some Benadryl/Allegra/Zantac and plan to monitor this rash. I suspect it will resolve on its own in about 2-3 days if drug rxn and slightly longer if EM. Obviously I will not dare give steroids with this live virus still around. Dx confirmed by email photos non-viral pustolosis (or folliculitis). 10/8/03 pt rash fading asymptomatic throughout entire process. Derm confirms IMP: EM minor vs toxin erythem vs rx rxn vs non-viral pustulosis.
Immediately following GARDASIL vaccine, nurse noted that he was pale. Immediately laid down on exam table where he fainted then clenched both arms Lt leg shook. Event lasted 1-2 sec.Responsive after that but C/O feeling terrible. Sats and glucose were fine. Neuro. exam normal. Patient report after he had not had any breakfast or liquids prior to visit.
TIRED AND RUN DOWN; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included unknown. This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) ,does not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  No concomitant medications were reported. On 12-MAR-2021, the subject experienced tired and run down. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of tired and run down was not reported. This report was non-serious.
Pt relays that 4 hours after she received the vaccine, she developed acute bilateral weakness in the legs and had to crawl up the stairs. "legs were not working"
On June 7th, I took the Second Dose Moderna, after that I have fever on the next two day, which is the 8 and the 9. Nothing happens on the 10, however after my mom came home from work she recognized a strange circle on my neck, it seems like an Adam?s apple. But it is really big. And I visited my doctor at the 14th the same month at 3:45, at first he suspect that I have a Thyromegaly.  And I took the Blood Test. However after a several day, the test came out and it says I have a Hyperthyroidism. He advice me to report to VAERS and give me an orders to take the Thyroid Ultrasound, and the Thyroid Uptake Scan. I already made appointments, and I will do it the next 2 weeks.
Arm sore by the evening as expected. Vaccine did not hurt going in as in comparison to the first dose. By next morning 4/13, arm was so sore that couldn't lift it out of bed. Overall malaise, sick to stomach that couldn't drink coffee; stayed in bed until 12:30pm since still felt a bit nauseated. By evening ate some. Felt similar to Flu-like symptoms. Next day, felt better and arm was not as sore by then. Patient did not call doctor. Patient took extra doses of Ibuprofen to help with the soreness.
This case was reported by a healthcare professional and described the occurrence of lightheadedness in a female subject aged between 20 and 29 years old who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included vomiting, prior to receiving the vaccination. On the morning of 20 October 2010 the subject received unspecified dose of ENGERIX B (20 mcg, unknown route, unknown arm). On the morning of 20 October 2010, less than one day after vaccination with ENGERIX B, the subject experienced lightheadedness and vomiting. The subject attended the Emergency Room, but was not hospitalized. On 20 October 2010, the events were resolved. The healthcare professional considered the event of lightheadedness was probably related to vaccination with ENGERIX B, and the event of vomiting was possibly related to vaccination with ENGERIX B. The healthcare professional reported that 3 subjects had experienced lightheadedness after vaccination with ENGERIX B. This is case 1 of 3 (see case IDs A0888943A and A0888946A for the other reports). Follow-up information was received on 10 November 2010 via physician who reported the 21-year old subject's immunization series with ENGERIX B was discontinued. At the time of the report no other information was provided. The lot number was reported as AHBV855AA from the reporter; however, based on a safety lot number review, the lot number was updated to AHBVB855AA.
shivers; Tiredness; This case was reported by a consumer via call center representative and described the occurrence of shivers in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 17th November 2019, the patient received Shingrix (intramuscular) .5 ml. On 18th November 2019, 1 days after receiving Shingrix, the patient experienced shivers and tiredness. On 19th November 2019, the outcome of the shivers and tiredness were recovered/resolved.   It was unknown if the reporter considered the shivers and tiredness to be related to Shingrix.  Additional details were provided as follows: The case was reported by the wife of the patient. The patient received Shingrix and experienced tiredness and shivers for 1 day. This case linked with US2020031411, reported for patient's husband.
At the time there was no pain or itchiness, only tenderness and pain the following 3 days.  There was also an undefined lump underneath the injection site that was tender like the rest of my arm.  Now, exactly 7 days later, the lump is more defined and very itchy. The skin is pink and slightly inflamed.
Woke up feeling fine other than a sore arm at the injection site. Around 9 am began feeling very tired, whole body seemed to ache. Headache and nausea. Slept for 2 1/2 hours. Less tired. Body aches continued. Chills. Took ibuprophen through the day.
she felt that her legs felt weak; dizziness and weakness; headache went to her right side. Had chest pain; dizziness and weakness; hard time taking inhaler as she had a hard time breathing; Had chest pain, left side above her breast; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). This is a report received from Pfizer sponsored program. A female patient of unspecified age received bnt162b2 (COMIRNATY, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number, Expiry date was not reported), dose 1 via an unspecified route of administration, administered on 01Sep2021 as dose 1, single for covid-19 immunisation. The patient medical history included loss of smell and other Covid symptoms started couple of months ago (patient thought she had Covid) and she was tested negative but still patient felt she had Covid. The concomitant medications were not reported. On an unspecified date in Sep2021, the patient experienced dizziness and weakness on 2nd day after vaccine. and 3rd day after getting the first dose of the vaccine. On 04Sep2021, she felt that her legs felt weak (On her 4th day from vaccination). On an unspecified date in Sep2021, the patient also experienced a hard time taking inhaler as she had a hard time breathing and headache went to her right side and had chest pain, left side above her breast. Asking if she could take the second dose after all these. The patient was able to speak to her doctor at the time of events. The patient got her first dose of the vaccine on 01Sep2021 and was wondering if we have info on how soon can she expect antibodies as she has only gotten her first dose 7 days from today. Asking how soon after her first dose can she take an antibody test and that if she would have some level of protection after her first dose of the vaccine. The patient lab test was included as Covid test: negative on an unspecified date. The clinical outcome of the events was unknown at the time of the report.  information about lo/batch number has been requested.